Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT04156958
Brief Title: Fruquintinib as Second-line Treatment for Advanced/Metastatic Biliary Tract Adenocarcinoma (FSTAMBTA)

First Submitted : November 6, 2019
First Submitted that Met QC Criteria : November 6, 2019
First Posted : November 8, 2019

Last Update Submitted that Met QC Criteria : November 6, 2019
Last Update Posted : November 8, 2019